SOURCE: PHT Corporation

March 03, 2008 09:49 ET

PHT to Unveil Revolutionary SitePad™ Tablet for Site-Based Questionnaire Data Capture at DIA EuroMeeting

ePRO Leader Executives Also to Present Groundbreaking Sessions on Future of eSource, Guidance and Regulations in Age of Electronic Records

BOSTON, MA--(Marketwire - March 3, 2008) - PHT Corporation, the leading provider of electronic patient reported outcome (ePRO) solutions used in more than 345 clinical trials worldwide, will reveal the future of site-based questionnaire data capture at the 20th Annual DIA EuroMeeting in Barcelona, 3-5 March 2008.

At exhibit booth #193, PHT will demonstrate for the first time the SitePad Tablet, a breakthrough technology answer to intense market demand for complete and timely questionnaire and quality of life data captured at sites worldwide. The SitePad Tablet features a large touchpad screen, fingertip data entry, automatic symptom and eligibility calculations, high-speed data transmission and a simple user interface. The revolutionary device is ideal for trials with a site-based PRO component, such as oncology, pain, Alzheimer's, Hepatitis C, CNS indications, psychiatric indications, registry studies and Phase IV programs. Visitors to the PHT exhibit booth will be able to use the SitePad Tablet and be entered into a chance to win a new Samsung Q1 Ultra Mobile PC.

Additional PHT activity at EuroMeeting will include:

--  Dr. Valdo Arnera, PHT General Manager for Europe, will conduct a
    session on "Electronic Acquisition and Exchange of Clinical Data from Start
    to Finish: What's the Future of eSource?" on 4 March from 11:00-12:30
--  Dr. Stephen Raymond, PHT Chief Scientific Officer and Quality Officer,
    will conduct a session called, "Guidance and Regulations in the Age of
    Electronic Records" on 5 March from 16:00-17:30 pm
--  Opportunities to meet with PHT senior executives and ePRO thought
    leaders
    

For those who are unable to attend the EuroMeeting, on 28 March 2008 PHT will host a virtual worldwide launch of the SitePad Tablet in an hour-long event featuring interactive presentations and exclusive demonstrations of this landmark eSource solution. All virtual launch attendees will also be eligible to win a Samsung Q1 UMPC. To register, visit www.phtcorp.com/Tablet.

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 345 clinical trials by 90 biopharmaceutical clients around the world. The company's proven LogPad® and StudyPad® Systems deliver the voice of the patient -- directly and without distortion -- with reliable and timely self-reported data. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least nine NDA submissions, with five known approvals, to date. To learn more about how study sponsors worldwide are using ePRO to improve data quality, conduct smaller trials, and manage patient safety, enrollment and compliance in real time, visit www.phtcorp.com.

PHT, LogPad and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information